This is an educational program developed for oncologists, focusing on the treatment of HR+/HER2- metastatic breast cancer, biomarkers, and new treatment strategies. The program of this educational event is led by MUDr. Katarína Petráková, Ph.D., Prof. François Clément Bidard (France), and Prof. Giuseppe Curigliano (Italy) – leading experts in breast cancer treatment who will share their clinical experience and insights in patient care.